A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase
- 132 Downloads
Inhibition of tumor vasculature is an effective strategy for cancer therapy. Angiostatin could suppress tumor growth and metastasis by binding and inhibiting F1F0 ATP synthase on the endothelial cell surface. We previously screened a monoclonal antibody (McAb, McAb178-5G10), which specifically bound to ATPase on the surface of cells and showed an angiostatin-like activity. Here, we further generated a panel of CHO-mAb subclone stable expressing a humanized chimeric antibody from hybridoma cell McAb178-5G10 by gene engineer. And then, we successfully expressed the humanized antibody Hai178 at high level in a 5-L wave bioreactor. The vitro results showed that Hai178 retained the specific binding and antitumor activity of murine antibody. Furthermore, Hai178 also had a tumor therapeutic effect in tumor xenografts. These results paved the way for Hai178 as a therapeutic antibody in clinic.
KeywordsF1F0 ATP synthase Humanized chimeric antibody Stable cell line Tumor therapy
This work was supported by Major Scientific and Technological Special Project for “Significant New Drugs Creation” No. 2012ZX09103301-040.
Compliance with ethical standards
Conflicts of interest
- 2.Ma Z, Cao M, Liu Y, He Y, Wang Y, Yang C, et al. Mitochondrial F1Fo-ATP synthase translocates to cell surface in hepatocytes and has high activity in tumor-like acidic and hypoxic environment. Acta. Biochim Biophys. 2010;42:530–7.Google Scholar
- 15.Pan J, Sun LC, Tao YF, Zhou Z, Du XL, Peng L, et al. ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer. J Transl Med. 2011;(9):211.Google Scholar
- 26.Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, et al. Vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of egfr. Cancer Chemother Pharmacol. 2006;57:709–18.CrossRefPubMedGoogle Scholar